Pathology Department, Tehran University of Medical Sciences, Tehran, Iran.
Pathology Department, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Cancer Rep (Hoboken). 2024 Nov;7(11):e70052. doi: 10.1002/cnr2.70052.
Laryngeal squamous cell carcinoma (LSCC) is a commonly occurring malignancy in the head and neck region. However, due to the heterogeneity of primary tumor sites, tumor behavior, and molecular mechanisms, there is currently no consensus on the accuracy of clinicopathological prognostic factors for individual cases. Tumor histopathologic behavior remains a crucial factor in predicting aggressiveness. Recent studies have shown that peritumoral tumor budding (TB) combined with cell nest size (CNS) is a reliable marker for predicting lymph node metastasis, advanced cancer prognosis, and therapeutic response in SCCs of different origins.
This study aims to investigate the relationship between TB and CNS in the context of nodal metastasis and overall prognosis in patients diagnosed with LSCC. Our objective is to establish the significance of TB and CNS status as a cost-effective, easily assessed, and highly reliable prognostic factor among this patient population.
In this retrospective cross-sectional study, we analyzed 128 LSCC cases that underwent total laryngectomy at Amir Alam Hospital. We evaluated TB and CNS based on the Boxberg et al.
Our study demonstrated a significant correlation between TB, and nodal involvement (p = 0.015), vascular invasion (p = 0.035), and mortality rate (p = 0.001), as well as a significant statistical correlation between high TB and extra-laryngeal extension (p = 0.006), clinical stage (p = 0.011), and mortality rate (p = 0.001). Moreover, small nest size was also associated with the clinical stage (p = 0.047), extra-laryngeal extension (p = 0.015), and mortality rate (p < 0.001). Based on our results, TB, CNS, and clinical stage are independent prognostic factors for mortality rate and are correlated with disease-specific survival.
Given the effect of TB and CNS on the overall prognosis and survival of patients with LSCC, evaluating these two factors on routine H&E microscopic examination of LSCC specimens is recommended to facilitate individualized risk assessment and treatment planning.
喉鳞状细胞癌(LSCC)是头颈部常见的恶性肿瘤。然而,由于原发肿瘤部位、肿瘤行为和分子机制的异质性,目前对于个体病例的临床病理预后因素的准确性尚无共识。肿瘤组织病理学行为仍然是预测侵袭性的关键因素。最近的研究表明,肿瘤周围肿瘤芽(TB)与细胞巢大小(CNS)的结合是预测淋巴结转移、高级别癌症预后和不同起源的 SCC 治疗反应的可靠标志物。
本研究旨在探讨 LSCC 患者中淋巴结转移和总体预后中 TB 和 CNS 的关系。我们的目的是确定 TB 和 CNS 状态作为该患者人群中具有成本效益、易于评估和高度可靠的预后因素的意义。
在这项回顾性横断面研究中,我们分析了在 Amir Alam 医院接受全喉切除术的 128 例 LSCC 病例。我们根据 Boxberg 等人的研究评估了 TB 和 CNS。我们的研究表明,TB 与淋巴结受累(p=0.015)、血管侵犯(p=0.035)和死亡率(p=0.001)之间存在显著相关性,高 TB 与喉外延伸(p=0.006)、临床分期(p=0.011)和死亡率(p=0.001)之间也存在显著的统计学相关性。此外,小巢大小也与临床分期(p=0.047)、喉外延伸(p=0.015)和死亡率(p<0.001)相关。基于我们的结果,TB、CNS 和临床分期是死亡率的独立预后因素,与疾病特异性生存相关。
鉴于 TB 和 CNS 对 LSCC 患者整体预后和生存的影响,建议在 LSCC 标本的常规 H&E 显微镜检查中评估这两个因素,以促进个体化风险评估和治疗计划。